Arsil%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252520dx

# Arsil-DX ## Overview **Arsil-DX** is a brand name typically associated with a combination preparation containing **Dextromethorphan HBr** (antitussive) and **Chlorpheniramine Maleate** (first-generation antihistamine). It is commonly used for the symptomatic relief of upper respiratory symptoms associated with the common cold or allergic rhinitis. ## Primary Indications * Temporary relief of cough due to minor throat and bronchial irritation. * Relief of sneezing, runny nose, and itchy/watery eyes due to hay fever or upper respiratory allergies. ## Adult Dosing * **Dextromethorphan:** 10–20 mg every 4–6 hours as needed. Maximum: 120 mg/24 hours. * **Chlorpheniramine:** 4 mg every 4–6 hours as needed. Maximum: 24 mg/24 hours. * *Note:* Always follow specific product labeling, as formulations vary by manufacturer. ## Pediatric Dosing * **Children < 6 years:** Not recommended (safety and efficacy not established; avoid due to risk of serious adverse events). * **Children 6–12 years:** * Dextromethorphan: 5–10 mg every 4–6 hours (Max: 60 mg/24 hours). * Chlorpheniramine: 2 mg every 4–6 hours (Max: 12 mg/24 hours). * **Adolescents (12+ years):** Follow adult dosing. ## Dose Adjustments * **Renal/Hepatic Impairment:** No standard adjustment guidelines exist for this combination. Use with caution; initiate at the lowest effective dose due to decreased clearance of antihistamines and potential sedation. * **Geriatric:** Avoid if possible (Beers Criteria). First-generation antihistamines (chlorpheniramine) have high anticholinergic potential in patients > 65 years, increasing risk of falls, delirium, and urinary retention. ## Contraindications * Hypersensitivity to any component. * Concomitant use of MAO inhibitors (MAOIs) or within 14 days of discontinuing MAOIs (risk of serotonin syndrome). * Narrow-angle glaucoma. * Symptomatic prostatic hypertrophy (due to anticholinergic effects). * Severe asthma or acute bronchospasm. ## Adverse Effects * **Common:** Drowsiness, sedation, dizziness, blurred vision, dry mouth, constipation, and urinary retention. * **Serious:** Paradoxical excitation (especially in children), cardiac arrhythmias, seizures, and severe hypotension. ## Key Drug Interactions * **MAOIs:** Absolute contraindication due to risk of serotonin syndrome and hypertensive crisis. * **CNS Depressants:** Alcohol, benzodiazepines, and opioids may cause profound additive sedation. * **Anticholinergics:** Additive effects increase the risk of confusion, urinary retention, and ileus. ## Monitoring * Monitor for excessive sedation or respiratory depression. * Assess effectiveness in cough control; if cough persists beyond 7 days or is accompanied by high fever/rash, discontinue and seek medical evaluation. * Monitor blood pressure periodically in patients with underlying cardiovascular disease. ## Clinical Pearls * **Sedation Warning:** Chlorpheniramine is sedating; advise patients to use caution when performing tasks requiring mental alertness (e.g., driving). * **Hidden Ingredients:** Check if the product contains alcohol, as many liquid cough preparations do. * **Avoid Overlap:** Ensure patients are not taking other medications containing dextromethorphan or antihistamines (e.g., multi-symptom cold flu "nighttime" formulations) to prevent accidental overdose. *** **Educational Disclaimer:** This information is for educational purposes and does not replace professional clinical judgment. Always verify current prescribing information, local clinical protocols, and manufacturer-specific labeling before administration.